Technical Analysis for DXR - Daxor Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 11.0 | 0.82% | 0.09 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical DXR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Doji - Bullish? | Reversal | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.82% | |
| Inside Day | Range Contraction | 0.82% | |
| Oversold Stochastic | Weakness | 0.82% | |
| Stochastic Buy Signal | Bullish | 1.15% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Rose Above Lower Bollinger Band | 7 days ago |
| Up 3% | 7 days ago |
| Up 2% | 7 days ago |
| Up 1% | 7 days ago |
| Fell Below Previous Day's Low | 7 days ago |
Get this analysis on your stocks daily!
- Earnings date: 01/01/2016
Daxor Corporation Description
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Hypertension Disorders Hematology Heart Failure Radiology Anemia Red Blood Cell Blood Transfusion Medicine Blood Transfusion Kidney Failure Science Medical Device Manufacturing Blood Volume Hematopathology Polycythemia Syncope
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.0758 |
| 52 Week Low | 10.6 |
| Average Volume | 13,309 |
| 200-Day Moving Average | 14.31 |
| 50-Day Moving Average | 12.29 |
| 20-Day Moving Average | 11.87 |
| 10-Day Moving Average | 11.42 |
| Average True Range | 0.69 |
| ADX | 13.77 |
| +DI | 13.67 |
| -DI | 22.13 |
| Chandelier Exit (Long, 3 ATRs ) | 11.38 |
| Chandelier Exit (Short, 3 ATRs ) | 12.66 |
| Upper Bollinger Band | 13.10 |
| Lower Bollinger Band | 10.63 |
| Percent B (%b) | 0.15 |
| BandWidth | 20.80 |
| MACD Line | -0.37 |
| MACD Signal Line | -0.26 |
| MACD Histogram | -0.1149 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.83 | ||||
| Resistance 3 (R3) | 11.78 | 11.47 | 11.69 | ||
| Resistance 2 (R2) | 11.47 | 11.26 | 11.49 | 11.64 | |
| Resistance 1 (R1) | 11.23 | 11.13 | 11.35 | 11.28 | 11.60 |
| Pivot Point | 10.92 | 10.92 | 10.98 | 10.94 | 10.92 |
| Support 1 (S1) | 10.68 | 10.71 | 10.80 | 10.73 | 10.40 |
| Support 2 (S2) | 10.37 | 10.58 | 10.39 | 10.36 | |
| Support 3 (S3) | 10.13 | 10.37 | 10.31 | ||
| Support 4 (S4) | 10.18 |
